CSBR
CSBR
NASDAQ · Life Sciences Tools & Services

Champions Oncology Inc

$4.67
-0.11 (-2.30%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +530.6% upside
Low Target $20.89
Average Target $29.45
High Target $33.06
Current Price $4.67
Current
$4.67
Target
$29.45
$20.89 $29.45 avg $33.06
Scenario Analysis
Bear Case
$20.89
347.3%
Low target
Base Case
$29.45
+530.6%
Avg target
Bull Case
$33.06
+607.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$8.31
-43.8% from high
52-Week Low
$4.59
+1.7% from low
Target vs 52W High
$29.45
+254.4% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 34 79% $369.21 -46.8%
DHR
Danaher Corp
Strong Buy 31 84% $158.11 -31.3%
A
Agilent Technologies Inc
Buy 30 73% $64.69 -62.6%
IQV
Iqvia Holdings Inc
Strong Buy 26 92% $82.96 -69.4%
WAT
Waters Corp
Strong Buy 28 75% $189.60 -59.0%
MTD
Mettler-Toledo International
Hold 19 47% $170.43 -90.2%
ILMN
Illumina Inc
Hold 28 54% $169.36 -19.2%
WST
West Pharmaceutical Services
Strong Buy 21 95% $136.24 -66.9%